Diabetis
PrivateLast Round
Grant
Jun 28, 2024
Total Funding Raised
$2.46M
Company Overview
Diabetis operates in Healthcare & Life Sciences and is based in Vilnius. Its latest recorded funding round was a Grant round in June 2024.
Diabetis is a medical technology company that develops Feetsee, a non-contact, at-home monitoring device designed to detect early signs of diabetic foot ulcers through thermal and optical imaging.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Healthcare Analytics, Health IoT
Business Model
B2C
Customer Profile
Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Diabetis Comparables
Compare Diabetis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Orthofeet | 83% | |
| Propét USA | 76% | |
| Compedica | 49% |
For institutional investors. Book with your work email.
Diabetis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 28, 2024 | ||||
| Grant | Jan 26, 2024 | ||||
| Series A | Mar 22, 2022 | ||||
| Accelerator | May 1, 2021 |
For institutional investors. Book with your work email.
Diabetis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| BAJ Accelerator | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 40% MoM to 4.5K.
- Jul 20, 2025
Grew 100% QoQ from 5 to 10 employees.
For institutional investors. Book with your work email.
Diabetis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Diabetis's valuation, stock price, and market status.
Is Diabetis a public or private company?
Diabetis is a private company.
What is the current stock price of Diabetis?
Diabetis is a private company, so its shares have no public market price. Caplight tracks Diabetis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Diabetis worth (valuation)?
Valuation information for Diabetis is not publicly available.
Can I buy Diabetis stock?
Diabetis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Diabetis's last funding round?
Diabetis's most recent funding round was Grant on June 28, 2024.
Who are the main investors in Diabetis?
Key investors in Diabetis include European Innovation Council Fund, BAJ Accelerator.
Will Diabetis IPO soon?
No public IPO plans have been announced for Diabetis.
How can I track Diabetis secondary market activity?
Caplight tracks bids, offers, and trades in Diabetis's shares on secondary markets.